Cardiovascular Complications of Sickle Cell Disease
common.study.values.description
“Cardiovascular Complications of Sickle Cell Disease”
In this research study, we are using heart imaging exams and blood testing, in order to gain an improved understanding of the pulmonary (lung) hypertension and cardiovascular (heart) complications that often occur in sickle cell patients. Information gathered from the healthy volunteers that participate in this study will be compared to information from the sickle cell patients in this study in order to help further our understanding.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-no
common.study.methods.is-healthy-no
Procedure - MRI, Transthoracic Echocardiography, tonometry, EKG
Unless contraindicated, subjects will receive Regadenoson and Gadolinium contrast agent during the Cardiac magnetic resonance. The tonometer, EKG, and echo are non-invasive procedures.
participant.views.study.view.additional
participant.views.study.view.scientific-title
Cardiovascular Complications of Sickle Cell Disease
common.study.values.clinical-trial-id
NCT01044901
participant.views.study.view.id
1aMj3b
